Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -94.76% is 17% above its 2-year average of -114.40%, near the high end of its 2-year range (-230.10%–-63.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.88% above its 12-month average of -98.58%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -94.76%.
RETURN ON INVESTED CAPITAL (ROIC)
-94.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-98.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.88%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.29%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
-234.96%
vs the sector median at left
Alumis Inc.
Market Cap
$844.28M
Return on Invested Capital (ROIC)
-94.76%
TTM Avg
-98.58%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$837.43M
Return on Invested Capital (ROIC)
-7.99%
TTM Avg
-8.85%
3Y Avg
-21.37%
5Y Avg
-42.56%
Market Cap
$852.55M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
Market Cap
$856.30M
Return on Invested Capital (ROIC)
-37.39%
TTM Avg
-65.53%
3Y Avg
-61.64%
5Y Avg
-93.68%
Market Cap
$866.15M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Return on Invested Capital (ROIC)
-28.69%
TTM Avg
-21.44%
3Y Avg
-33.52%
5Y Avg
-49.04%
Market Cap
$819.44M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
Market Cap
$812.20M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
Market Cap
$786.48M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $844.28M | -94.76% | -98.58% | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | -7.99% | -8.85% | -21.37% | -42.56% |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | -31.17% | -29.64% | -85.48% | -85.48% |
| Jade Biosciences, Inc. (JBIO)vs › | $856.30M | -37.39% | -65.53% | -61.64% | -93.68% |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -28.69% | -21.44% | -33.52% | -49.04% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | -9.77% | 8.57% | -11.39% | -51.99% |
| InMode Ltd. (INMD)vs › | $812.20M | 9.20% | 13.08% | 19.17% | 23.78% |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | -12.00% | -7.53% | -5.45% | -2.27% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | -25.25% | -75.69% | -67.13% | -61.15% |
ROIC
-94.8%
ROE
-97.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -94.76% |
| 2026-03-31 | -74.48% |
| 2025-12-31 | -132.19% |
| 2025-09-30 | -107.90% |
| 2025-06-30 | -83.58% |
| 2025-03-31 | -176.60% |
| 2024-12-31 | -103.68% |
| 2024-09-30 | -63.91% |
| 2024-06-30 | -80.95% |
| 2024-03-31 | -110.25% |
| 2023-12-31 | -230.10% |
